Sodium Intake and Health: What Should We Recommend Based on the Current Evidence?

被引:60
|
作者
Mente, Andrew [1 ,2 ]
O'Donnell, Martin [1 ,3 ]
Yusuf, Salim [1 ,4 ]
机构
[1] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON L8S 4L8, Canada
[3] Natl Univ Ireland, HRB Clin Res Facil, Galway H91 TK33, Ireland
[4] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada
关键词
sodium; salt; blood pressure; cardiovascular disease; mortality; renin-angiotensin-aldosterone system; population health; NUTRITION-EXAMINATION-SURVEY; PLASMA-RENIN ACTIVITY; URINARY SODIUM; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; DIETARY-SODIUM; POTASSIUM EXCRETION; NATIONAL-HEALTH; ELECTROLYTE EXCRETION; ALL-CAUSE;
D O I
10.3390/nu13093232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Several health organizations recommend low sodium intake (below 2.3 g/day, 5.8 g/day of salt) for entire populations, on the premise that lowering of sodium intake, irrespective of its level of intake, will lower blood pressure and, in turn, will result in a lower incidence of cardiovascular disease. These guidelines were developed without effective interventions to achieve long term sodium intakes at low levels in free-living individuals and without high-quality evidence that low sodium intake reduces cardiovascular events (compared with average levels of intake). In this review, we examine whether advice to consume low amounts of sodium is supported by robust evidence. We contend that current evidence indicates that most people around the world consume a moderate range of dietary sodium (3 to 5 g/day), that this level of intake is associated with the lowest risk of cardiovascular disease and mortality, and that the risk of adverse health outcomes increases when sodium intakes exceeds 5 g/day or is below 3 g/day. While the current evidence has limitations, it is reasonable, based upon prospective cohort studies, to suggest a mean target of below 5 g/day in populations, while awaiting the results of large randomized controlled trials of sodium reduction on cardiovascular disease and death.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] What should we eat? Evidence from observational studies
    Adams, Stephen M.
    Standridge, John B.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (07) : 744 - 748
  • [32] Recommendations on sodium intake for cardiovascular health: conviction or evidence?
    Lechner, Katharina
    Schunkert, Heribert
    EUROPEAN HEART JOURNAL, 2020, 41 (35) : 3374 - 3375
  • [33] What should we advocate for in for-profit mental health care, and how should we do it?
    Sabin, JE
    PSYCHIATRIC SERVICES, 1996, 47 (10) : 1061 - +
  • [34] What confidentiality standards should we advocate for in mental health care, and how should we do it?
    Sabin, JE
    PSYCHIATRIC SERVICES, 1997, 48 (01) : 35 - &
  • [35] On what evidence-base do we recommend self-monitoring of blood glucose?
    Kolb, Hubert
    Kempf, Ketstin
    Martin, Stephan
    Stumvoll, Michael
    Landgraf, Ruediger
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (02) : 150 - 156
  • [36] Evidence-based Health Informatics: How Do We Know What We Know?
    Ammenwerth, E.
    METHODS OF INFORMATION IN MEDICINE, 2015, 54 (04) : 298 - 307
  • [37] Should we recommend reductions in saturated fat intake or in red/processed meat consumption? The SUN prospective cohort study
    Dominguez, Ligia J.
    Bes-Rastrollo, Maira
    Javier Basterra-Gortari, Francisco
    Gea, Alfredo
    Barbagallo, Mario
    Martinez-Gonzalez, Miguel A.
    CLINICAL NUTRITION, 2018, 37 (04) : 1389 - 1398
  • [38] WHY SHOULD WE WORRY ABOUT SODIUM INTAKE, IF WE INCLUDE A DIURETIC IN THE HYPERTENSION TREATMENT REGIMEN ?
    Lackland, Daniel T.
    JOURNAL OF HYPERTENSION, 2023, 41 : E153 - E153
  • [39] What should we tell patients with heart failure about sodium restriction and how should we counsel them?
    Lennie T.A.
    Chung M.L.
    Moser D.K.
    Current Heart Failure Reports, 2013, 10 (3) : 219 - 226
  • [40] Application of Continuous Renal Replacement Therapy: What Should We Consider Based on Existing Evidence?
    Hanafusa, Norio
    BLOOD PURIFICATION, 2015, 40 (04) : 312 - 319